Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)

被引:143
|
作者
Kumari, Archana [1 ,3 ]
Singh, Rajesh K. [2 ]
机构
[1] Rayat Bahra Inst Pharm, Dept Pharmaceut Chem, Nangal Shahidan 146104, Punjab, India
[2] Shivalik Coll Pharm, Dept Pharmaceut Chem, Nangal 140126, Punjab, India
[3] IK Gujral Punjab Tech Univ, Fac Pharm, Jalandhar, Punjab, India
关键词
Morpholine; Pharmacophore; Structure-activity relationship (SAR); Pharmacokinetic; Pharmacological profile; DEPENDENT PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE PI3K; IN-VITRO METABOLISM; (PI3K)/MAMMALIAN TARGET; BIOLOGICAL EVALUATION; SELECTIVE INHIBITOR; ASYMMETRIC-SYNTHESIS; ANTIFUNGAL AGENTS; MAMMALIAN TARGET; SCHIFF-BASES;
D O I
10.1016/j.bioorg.2020.103578
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Morpholine is a versatile moiety, a privileged pharmacophore and an outstanding heterocyclic motif with wide ranges of pharmacological activities due to different mechanisms of action. The ability of morpholine to enhance the potency of the molecule through molecular interactions with the target protein (kinases) or to modulate the pharmacokinetic properties propelled medicinal chemists and researchers to synthesize morpholine ring by the efficient ways and to incorporate this moiety to develop various lead compounds with diverse therapeutic activities. The present review primarily focused on discussing the most promising synthetic leads containing morpholine ring along with structure-activity relationship (SAR) to reveal the active pharmacophores accountable for anticancer, anti-inflammatory, antiviral, anticonvulsant, antihyperlipidemic, antioxidant, antimicrobial and antileishmanial activity. This review outlines some of the recent effective chemical synthesis for morpholine ring. The review also highlighted the metabolic liability of some clinical drugs containing this nucleus and various researches on modified morpholine to enhance the metabolic stability of drugs as well. Drugs bearing morpholine ring and those under clinical trials are also mentioned with the role of morpholine and their mechanism of action. This review will provide the necessary knowledge base to the medicinal chemists in making strategic structural changes in designing morpholine derivatives.
引用
收藏
页数:33
相关论文
共 50 条
  • [11] Structure-activity analysis of anandamide analogs: Relationship to a cannabinoid pharmacophore
    Thomas, BF
    Adams, IB
    Mascarella, SW
    Martin, BR
    Razdan, RK
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) : 471 - 479
  • [12] Review of Voltage-gated Calcium Channel α2δ Subunit Ligands for the Treatment of Chronic Neuropathic Pain and Insight into Structure-activity Relationship (SAR) by Pharmacophore Modeling
    Chen, Yuting
    Wu, Qingqing
    Jin, Zhengsheng
    Qin, Yanlan
    Meng, Fancui
    Zhao, Guilong
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (30) : 5097 - 5112
  • [13] Structure-activity relationship (SAR) modelling of mosquito larvicides
    Devillers, J.
    Doucet-Panaye, A.
    Doucet, J. P.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2015, 26 (04) : 263 - 278
  • [14] An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review
    Sharma, Neha
    Chaudhary, Anurag
    Sachdeva, Monika
    FUTURE MEDICINAL CHEMISTRY, 2023, : 2309 - 2323
  • [15] Microbial transformation of three bufadienolides by Nocardia sp and some insight for the cytotoxic structure-activity relationship (SAR)
    Zhang, Jian
    Sun, Yang
    Liu, Ji-Hua
    Yu, Bo-Yang
    Xu, Qiang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6062 - 6065
  • [16] Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship
    Wang, Zhen
    Xiong, Yongxia
    Peng, Ying
    Zhang, Xi
    Li, Shuang
    Peng, Yan
    Peng, Xue
    Zhuo, Linsheng
    Jiang, Weifan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 247
  • [17] Structure-activity relationship (SAR) studies of the tripos benchmark steroids
    Vendrame, R
    Coluci, VR
    Braga, RS
    Galvao, DS
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2002, 619 : 195 - 205
  • [18] Structure-activity relationship (SAR) investigations of tetrahydroquinolines as BKCa agonists
    Gore, Vijay K.
    Ma, Vu V.
    Yin, Ruoyuan
    Ligutti, Joe
    Immke, David
    Doherty, Elizabeth M.
    Norman, Mark H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3573 - 3578
  • [19] Chemistry of ginkgolides: structure-activity relationship as PAF antagonists
    Hu, LH
    Chen, ZL
    Cheng, XF
    Xie, YY
    PURE AND APPLIED CHEMISTRY, 1999, 71 (06) : 1153 - 1156
  • [20] Chemistry, design, and structure-activity relationship of cocaine antagonists
    Singh, S
    CHEMICAL REVIEWS, 2000, 100 (03) : 925 - 1024